Analisa Orta, MBA

As Co-Founder, I lead brand strategy, business development, and market expansion, overseeing everything from product development and packaging to retail partnerships, vendor events, and e-commerce growth. Our mission is to create a product that feels both approachable and elevated a small luxury that people can enjoy, gift, and share.

I oversee commercial strategy and sales execution across 26 states and 60+ field reps in retail and LTC channels. I connect business intelligence with brand activation, aligning cross-functional teams around patient access, field enablement, and launch readiness. COMMERCIAL GROWTH & SALES PERFORMANCE Increased NBRx by 215 units and maintained 32.2% market share by optimizing neurologist outreach and refining brand messaging. Boosted wholesaler sales 10.4% YTD and improved retention by deploying IRA education initiatives. Achieved 103.2% of regional quota and led the nation in NBRx volume. Grew NBRx volume by 14.1% YoY; ranked #1 regionally and #2 nationally in MDD and Alzheimer’s markets. TARGETING, DATA STRATEGY & LAUNCH READINESS Advanced launch readiness and NBRx performance by creating 20 strategic key account plans using IQVIA and CRM analytics. Developed reports that identified and re-engaged underperforming prescribers, improving retention and impact. Analyzed tools for abandonment/denials of payer claims. KOL DEVELOPMENT & CROSS-FUNCTIONAL INFLUENCE Expanded Speaker Bureau to 50 HCPs and added 4 KOLs to extend brand influence. Strengthened relationships with 20 KOLs and 3 key pharmacies representing 42% of regional business. Enhanced Omnichannel call plans by refining triggers such as call frequency and number of sales reps to see the same customer. FIELD LEADERSHIP & CULTURAL IMPACT Promoted 2 underperforming reps in Houston to the President’s Club through targeted coaching. Standardized sales excellence using a 30-60-90 onboarding plan and the FIND, FRAME, FOCUS, FULFILL coaching model. Achieved 100% cultural compliance in internal evaluations, reflecting a values-driven leadership style. OPERATIONAL EXECUTION & RESOURCE MANAGEMENT Managed regional budgets to align investments with performance goals and maximize ROI. Launched patient-centric resources, including multi-language materials, to improve reach and engagement.

COMMERCIAL STRATEGY & REVENUE GROWTH Delivered a 22% revenue increase by optimizing segmentation, targeting, and promotional mix. Led all forecasting efforts with <3% variance, improving lifecycle and investment planning. Supported new indication launches using competitive analytics and scenario modeling. FIELD EFFECTIVENESS & ACCESS STRATEGY Increased market share by designing custom dashboards and advanced targeting models. Built patient journey frameworks to shape payer strategy and reduce access barriers. Created performance KPIs that streamlined field execution and informed leadership decisions. DATA INNOVATION & EXECUTIVE REPORTING Rolled out real-time BI dashboards that elevated visibility and agility in executive decisions. Integrated CRM and real-world data to uncover growth opportunities and prioritize high-value accounts. Led analytics for advisory boards and senior meetings, delivering insights that shaped messaging and investments. CROSS-FUNCTIONAL LEADERSHIP Partnered with Marketing, Access, Medical Affairs, and HEOR to align analytics with core brand strategies. Translated data into field-facing narratives and simplified business cases used in sales training. Instilled a culture of data-driven thinking across commercial teams, improving executional alignment. STRATEGIC INSIGHT & COMMERCIAL IMPACT Built account prioritization models that aligned field teams with high-opportunity targets. Developed KPIs and dashboards that drove operational efficiency and improved visibility. Delivered insights for advisory boards that helped shape executive direction and messaging. Collaborated with Marketing and Sales to enable better decision-making through simplified data storytelling.

Managed full-cycle accounting, month-end close, and preparation of GAAP-compliant financial statements for aesthetics and medical device operations. Applied ASC 606 revenue recognition for product sales, buy-and-bill models, and physician financing programs. Oversaw cost accounting, inventory analysis, and margin reporting to support strategic pricing and sales initiatives. Ensured compliance with SOX controls, FDA-related financial documentation, and state/federal tax regulations. Partnered with sales, marketing, and operations teams on rebate accruals, promotional programs, and cross-functional financial planning. Utilized ERP systems and advanced Excel to streamline reporting processes and improve data accuracy. Delivered variance analyses, budget-to-actual reviews, and actionable insights to senior leadership.

I led FP&A for commercial and R&D functions during a pre-acquisition phase, focusing on forecasting, strategic investments, and financial modeling. Delivered accurate forecasts that improved executive confidence and decision-making. Uncovered cost-saving opportunities and increased margin through process streamlining. Built financial models that supported capital planning and new project business cases. Strengthened leadership alignment by enhancing reporting visibility.